InvestorsHub Logo
Followers 37
Posts 5184
Boards Moderated 0
Alias Born 03/09/2012

Re: FEARANDGREED post# 17952

Wednesday, 07/01/2020 3:32:19 PM

Wednesday, July 01, 2020 3:32:19 PM

Post# of 18805
I would drink to that. Aytu desperately needs to clear the air on Biolidics and get back to focusing on its portfolio of long-term products. Let any COVID-19 revenue just be icing on the cake. That was the whole reason for the buy upgrade when it was only two cents below where it is now.

"While Aytu has established rights to distribute up to 1M rapid tests in 2020, and therefore, has created potentially valuable future revenue opportunities, we view availability of the rapid tests as merely a play on a COVID-19 opportunity, and focus more on Aytu’s potential for organic growth as a fully-integrated specialty pharmaceutical company as an underappreciated value proposition."

https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+H.C.+Wainwright+Starts+Aytu+Biosciences+%28AYTU%29+at+Buy%3B+Organic+Growth/16945591.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AYTU News